IRIS
PORTA, CAMILLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.048
AS - Asia 5.519
EU - Europa 3.300
SA - Sud America 680
AF - Africa 208
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.774
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.877
CN - Cina 2.508
SG - Singapore 1.277
IE - Irlanda 1.171
HK - Hong Kong 612
VN - Vietnam 543
RU - Federazione Russa 510
BR - Brasile 488
FI - Finlandia 341
DE - Germania 310
FR - Francia 248
IN - India 127
UA - Ucraina 126
GB - Regno Unito 125
IT - Italia 122
SE - Svezia 104
ZA - Sudafrica 91
CA - Canada 85
AR - Argentina 78
BD - Bangladesh 71
MX - Messico 57
IQ - Iraq 54
PL - Polonia 47
JP - Giappone 46
NL - Olanda 42
TR - Turchia 39
ES - Italia 36
PK - Pakistan 28
EC - Ecuador 24
SA - Arabia Saudita 24
CO - Colombia 22
MA - Marocco 22
ID - Indonesia 21
PH - Filippine 20
TN - Tunisia 20
AT - Austria 19
UZ - Uzbekistan 19
MY - Malesia 18
VE - Venezuela 17
CZ - Repubblica Ceca 15
LT - Lituania 15
CL - Cile 14
PY - Paraguay 14
EG - Egitto 13
KE - Kenya 13
JO - Giordania 12
BE - Belgio 11
IL - Israele 11
MU - Mauritius 11
AU - Australia 10
AZ - Azerbaigian 9
KZ - Kazakistan 9
NP - Nepal 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
ET - Etiopia 7
PS - Palestinian Territory 7
UY - Uruguay 7
GR - Grecia 6
IR - Iran 6
OM - Oman 6
BG - Bulgaria 5
BO - Bolivia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
HU - Ungheria 5
LB - Libano 5
LV - Lettonia 5
PT - Portogallo 5
CR - Costa Rica 4
KG - Kirghizistan 4
PA - Panama 4
SN - Senegal 4
AL - Albania 3
AO - Angola 3
GA - Gabon 3
HR - Croazia 3
MD - Moldavia 3
MN - Mongolia 3
RE - Reunion 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
CH - Svizzera 2
CM - Camerun 2
DM - Dominica 2
EE - Estonia 2
EU - Europa 2
HN - Honduras 2
IS - Islanda 2
KH - Cambogia 2
LK - Sri Lanka 2
MM - Myanmar 2
NC - Nuova Caledonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
Totale 16.732
Salva come PNG Salva come JPEG
Città #
Dublin 1.171
San Jose 1.017
Chandler 870
Ashburn 704
Beijing 647
Hong Kong 599
Singapore 586
Dallas 527
Nanjing 382
Boardman 256
Princeton 230
Lawrence 222
Los Angeles 221
Helsinki 218
Lauterbourg 187
Jacksonville 168
Medford 167
Wilmington 165
Ho Chi Minh City 160
Nanchang 157
New York 133
Hanoi 131
Shanghai 112
Munich 107
Jiaxing 106
Changsha 100
Hangzhou 95
Shenyang 92
Hebei 91
Buffalo 87
Moscow 84
Redondo Beach 84
Johannesburg 74
Ann Arbor 64
Tianjin 58
Orem 54
São Paulo 46
Chicago 43
Tokyo 40
Dearborn 39
Toronto 39
Turku 39
Warsaw 39
Da Nang 37
Atlanta 36
Norwalk 36
Pavia 36
Chennai 33
London 31
The Dalles 31
Brooklyn 28
Santa Clara 27
Boston 26
Denver 25
Guangzhou 25
Fairfield 24
Frankfurt am Main 23
Stockholm 23
Amsterdam 22
San Francisco 22
Mexico City 21
Montreal 21
Zhengzhou 21
Baghdad 20
Haiphong 20
Columbus 19
Woodbridge 19
Manchester 18
Phoenix 18
Tashkent 18
Washington 18
Falkenstein 17
Nuremberg 17
Poplar 17
Redwood City 17
Jinan 16
Piscataway 16
Seattle 15
Kunming 14
Rio de Janeiro 14
Ankara 13
New Delhi 13
Belo Horizonte 12
Istanbul 12
Ningbo 12
Vienna 12
Amman 11
Brussels 11
Buenos Aires 11
Houston 11
Nairobi 11
Porto Alegre 11
Council Bluffs 10
Des Moines 10
Jeddah 10
Mumbai 10
Thái Nguyên 10
Baku 9
Biên Hòa 9
Can Tho 9
Totale 11.469
Salva come PNG Salva come JPEG
Nome #
Alterata espressione dei canali del Ca2+ in cellule progenitrici endoteliali di pazienti affetti da carcinoma cellulare renale, mielofibrosi idiopatica e tumore della mammella 157
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 145
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 137
[Eosinophilic infiltration of the gastrointestinal system: description of a clinical case simulating a lymphoproliferative process] 136
Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells. 135
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 135
Case report: long-lasting response in a patient with metastatic renal cell cancer receiving antitumor cytotoxic T lymphocytes 132
Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study. 130
Analysis of TERRA expression in Head and Neck Tumors. 130
Osteonecrosis of the Jaw in Patients with Metastatic Renal Cell Cancer Treated with Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature 126
Lingual metastasis from renal cell carcinoma: a case report and literature review. 123
Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patients. 122
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study 122
Orai1 and Transient Receptor Potential channels as novel molecular targets to impair tumor neovascularisation in renal cell carcinoma and other malignancies 121
Analysis of TERRA expression in Head and Neck Tumors. 117
Antiproliferative and cytokinetic effects of the specific Akt inhibitor perifosine on different solid tumor cell lines. 116
Circulating endothelial progenitor cells from patients with renal cell carcinoma display aberrant VEGF regulation, reduced apoptosis and altered ultrastructure 116
[Hypokalemic rhabdomyolysis and thiazide diuretics. 3 clinical cases] 115
Acute Kidney Injury in Cancer Patients 114
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib 114
Acute promyelocytic leukaemia (APL): chemotherapy or bone marrow transplantation? 113
5-methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil's cytotoxic activity in vivo. A phase II study in patients with advanced colon cancer 113
Ultrastructural and functional differences between normal and tumor endothelial progenitor cells 110
Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis 110
Endoplasmic reticulum Ca2+ handling and apoptotic resistance in tumor-derived endothelial colony forming cells 109
Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib 109
Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system 108
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 107
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. 106
Telomeric repeat-containing RNAs (TERRA) decrease in squamous cell carcinoma of the head and neck is associated with worsened clinical outcome 106
Store-operated Ca2+ entry is over-expressed in endothelial colony forming cells isolated from patients suffering of Renal Cellular Carcinoma. 105
Amifostine (WR-2721, Ethyol(TM)) can protect human endothelial but not tumor cells from cisplatin-induced cytotoxicity 104
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma 102
Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature 101
[Current approaches to the first-line treatment of clear-cell renal cell carcinoma] 100
Autoimmunity in thrombotic thrombocytopenic purpura 99
Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: a phase-II study 99
Sarcoidosis following beta-interferon therapy for multiple myeloma 99
Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors 99
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy 98
Phenotypic and functional characterization of endothelial progenitor cells isolated from peripheral blood of renal cell carcinoma patients 98
Verapamil inhibits to different extents agonist-induced Ca2+ transients in human tumor cells and in vitro tumor cell growth 98
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 98
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas 97
Eosinophils and C4 predict clinical failure of combination imunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients 96
Ocular involvement in acute thrombotic thrombocytopenic purpura 96
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy 96
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis? 96
Thrombotic thrombocytopenic purpura resistant to plasma-exchange: salvage treatment with high-dose IgG or vincristine. Italian Cooperative Group for TTP 95
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 95
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 95
Cationic protein-rich supernatants of cultured eosinophils from IL-2-treated patients have no cytotoxic activity on human renal cell carcinoma and melanoma cells: A preliminary report 94
Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients 94
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 94
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis 94
Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel 94
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial 94
Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? the experience of Italian centers 93
Store-operated Ca2+ entry is over-expressed in endothelial colony forming cells isolated from tumoral patients; its role in cell proliferation and tubulogenesis 92
Concurrent intra-arterial carboplatin administration and radiation therapy for the tretment of advanced head and neck squamous cell carcinima: short term results. 92
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma 91
Algorithms in the first-line treatment of metastatic clear cell renal cell carcinoma—analysis using diagnostic nodes 91
Chronic Epstein-Barr virus infection 91
Cytokinetic and pro-apoptotic effects induced by inhibition of Aurora Kinases: a novel strategy for malignant mesothelioma treatment. 90
Thrombotic Thrombocytopenic Purpura In Systemic Lupus-erythematosus 90
[The diagnostic difficulties in a case of Behçet's disease] 90
Clinical impact of Pancreatic metastases from renal cell carcinoma: A multicenter retrospective analysis 90
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: Final results from an expanded-access trial 89
Nitrite/nitrate balance during photoinduced cerebral ischemia in the rat determined by high-performance liquid chromatography with UV and electrochemical detection 88
PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises 88
A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer 88
Effect of different platelet agonists on intracellular free Ca++ concentrations in human tumor cells: possible role in tumor growth 87
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 87
Dovitinib (CHIR258, TKI258): Structure, development and preclinical and clinical activity 86
Rebuttal to: The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism 86
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: A new pharmacodynamic marker? 86
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature 86
Targeting angiogenesis in metastatic renal cell carcinoma 86
Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis 86
Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation 86
Store-operated Ca2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients 85
Editorial Comment from Dr Porta et al. to Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA 85
Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient 85
Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: A systematic review and meta-analysis 85
Increased serum lipase with associated normoamylasemia in cancer patients 85
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP 84
Tivantinib (ARQ197) in hepatocellular carcinoma 84
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents 84
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity? 83
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma 83
Targeted therapy for renal cell carcinoma: Focus on 2nd and 3rd line 83
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 83
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis 83
Targeting Stim and Orai proteins as an alternative approach in anticancer therapy 83
Platelet agonists and calcium homeostasis in endothelial cells: possible role in the interaction of endothelium with hemostatic system 83
Hypocholesterolemia and acute myeloid leukemia (AML) 82
Apoptosis and cell cycle status of hematopoietic progenitor cells in patients with severe refractory rheumatoid arthritis candidates to autografting 82
Corrigendum to Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis [Ann Oncol 26, 2015 2107-2113] (doi: 10.1093/annonc/mdv315)] 82
Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma 82
Opening an onconephrology clinic: recommendations and basic requirements 81
Totale 9.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 29 14
2021/2022836 9 2 35 8 18 11 8 56 47 23 152 467
2022/20232.824 363 212 47 175 187 236 1 134 1.350 15 72 32
2023/20241.019 136 189 36 60 92 286 16 58 7 40 59 40
2024/20252.945 88 250 102 62 41 132 77 241 764 107 355 726
2025/20266.947 591 477 869 642 924 290 1.544 310 612 473 215 0
Totale 17.053